癌症登記軟體市場規模、佔有率和成長分析（按類型、部署模型、資料庫、功能、最終用戶、區域）：產業預測（2024-2031）

2023年全球癌症登記軟體市場規模預計為7067萬美元，從2024年的7809萬美元成長到2031年的1.7358億美元，在預測期內（2024-2031年）成長10.5%，預計將以年複合成長率

由於對有效癌症管理、醫療品質提高和成本降低的需求不斷增加，癌症登記軟體市場正在顯著成長。這種先進的資料庫系統在組織、收集和儲存患者資料以評估治療結果方面發揮關鍵作用，這有助於改善資訊管理和對癌症登記資料的存取。擴大使用癌症患者登記資料進行市場監測以及電子健康記錄(EHR) 的激增進一步推動了這一成長。此外，最近的產品核准和推出也有助於市場擴張。對工作流程最佳化和減少醫生工作量的需求正在顯著推動先進軟體解決方案在醫療保健環境中的整合。政府對公共衛生的關注、對醫療基礎設施的投資以及旨在遏制醫療成本上升的舉措都與市場的加速發展有關。此癌症登記解決方案的主要優勢，包括簡化的工作流程、自動化病例登記和癌症病例成長，預計將推動其採用。此外，各個政府機構正在積極推動癌症登記處的建立，這可能會推動市場成長。在預測期內，這些因素結合在一起，使癌症登記軟體市場走上強勁的軌道，將其定位為現代醫療保健管理策略的重要組成部分。

目錄

介紹

• 分析目的
• 定義
• 市場範圍

分析方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析及影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 案例研究分析
• PESTEL分析
• 總體經濟指標

全球癌症登記軟體市場規模（按類型）/年複合成長率（2024-2031）

• 市場概況
• 獨立軟體
• 整合軟體

全球癌症登記軟體市場規模（依部署模式）/年複合成長率（2024-2031）

• 市場概況
• 本地
• 雲端基礎

全球癌症登記軟體市場規模（按資料庫）/年複合成長率（2024-2031）

• 市場概況
• 商業資料庫
• 公共資料庫

全球癌症登記軟體市場規模（按功能）/年複合成長率（2024-2031）

• 市場概況
• 符合州和聯邦法規的癌症報告
• 患者照護管理
• 產品性能評價
• 醫學研究/臨床研究

全球癌症登錄軟體市場規模（依最終用戶）/年複合成長率（2024-2031）

• 市場概況
• 政府機構/TPA（第三方管理員）
• 醫院/診所
• 製藥、生技和醫療設備公司
• 私人保險公司
• 研究中心

全球癌症登記軟體市場規模/年複合成長率（2024-2031）

• 北美（按類型、部署模型、資料庫、功能、最終用戶）
  • 美國
  • 加拿大
• 歐洲（按類型、部署模型、資料庫、功能、最終用戶）
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家
• 亞太地區（按類型、部署模型、資料庫、功能、最終用戶）
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲（按類型、部署模型、資料庫、功能、最終用戶）
  • 巴西
  • 其他拉丁美洲
• 中東/非洲（按類型、部署模型、資料庫、功能、最終用戶）
  • 波灣合作理事會(GCC) 國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 年比收益成長（YoY）比較（2021-2023）

主要企業簡介

• IBM Watson Health
• Oracle Corporation
• Siemens Healthineers
• Cerner Corporation
• Epic Systems Corporation
• MEDITECH
• Allscripts Healthcare Solutions
• McKesson Corporation
• Philips Healthcare
• GE Healthcare
• Inova Health System
• Varian Medical Systems
• Roche Diagnostics
• TomoTherapy Inc.
• Health Information Systems
• Elekta
• ONCO, Inc.
• Conduent, Inc.
• Ordinate Corporation
• Volpara Health Limited

結論和建議

Global Cancer Registry Software Market size was valued at USD 70.67 Million in 2023 poised to grow from USD 78.09 Million in 2024 to USD 173.58 Million by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

The cancer registry software market is experiencing significant growth driven by the increasing demand for effective cancer management, enhanced healthcare quality, and reduced costs. This sophisticated database system plays a crucial role in organizing, collecting, and preserving patient data to evaluate treatment outcomes, thus fostering better information management and access to cancer registry data. The rise in the utilization of cancer patient registry data for market surveillance and the widespread adoption of Electronic Health Records (EHRs) further fuel this growth. Additionally, recent product approvals and launches contribute to market expansion. The demand for optimized workflows and the alleviation of physician workloads are substantially driving the integration of advanced software solutions in healthcare settings. Factors such as governmental focus on population health, investments in healthcare infrastructure, and initiatives aimed at controlling rising healthcare expenses correlate with an accelerated development of the market. Key benefits of these cancer registry solutions, including streamlined workflows, automated case registries, and the increase in cancer cases, are anticipated to bolster their adoption. Moreover, various governmental organizations are actively promoting the establishment of cancer registries, which is likely to expedite market growth. As we move through the projection period, the combination of these factors suggests a robust trajectory for the cancer registry software market, positioning it as an essential component of modern healthcare management strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cancer Registry Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cancer Registry Software Market Segmental Analysis

Global Cancer Registry Software Market is segmented by Type, Deployment Model, Database, Functionality, end user and region. Based on Type, the market is segmented into Standalone Software, Integrated Software. Based on Deployment Model, the market is segmented into On-premises, Cloud-based. Based on Database, the market is segmented into Commercial Databases, Public Databases. Based on Functionality, the market is segmented into Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies. Based on end user, the market is segmented into Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cancer Registry Software Market

The increasing focus on enhancing population health management and the efficient exchange of health information is a significant market driver for the Global Cancer Registry Software market. Governments worldwide are actively promoting the establishment of cancer registries to combat rising cancer incidence rates, with many agencies investing in digitization initiatives and the development of computerized illness registries. By facilitating real-time data collection and analysis, these software solutions enable better management of cancer care, resource allocation, and targeted public health strategies. As a result, the push for improved governmental healthcare systems is fueling demand for advanced cancer registry software solutions.

Restraints in the Global Cancer Registry Software Market

One of the significant market restraints for the Global Cancer Registry Software market is the increasing concern over data privacy and security. With family member information often intertwined with patient health data, the risk of data breaches poses a critical threat to confidentiality. Such incidents can lead to sensitive information falling into unauthorized hands, raising ethical and legal implications. Governments in developed economies are struggling to establish regulations that adequately protect privacy while promoting data accessibility for research and healthcare improvement. This regulatory uncertainty can slow software adoption and deter potential investments, thus hindering market growth in the cancer registry sector.

Market Trends of the Global Cancer Registry Software Market

The global cancer registry software market is witnessing a robust trend towards comprehensive data management coupled with increased global adoption, driven by the escalating need for precise cancer analytics in healthcare systems. Hospitals are increasingly integrating advanced registry software solutions to streamline the collection, processing, and organization of cancer-related patient data. This shift enhances the quality of oncology care, enabling healthcare providers to glean insights for better treatment protocols and resource allocation. Moreover, rising awareness of cancer epidemiology, coupled with regulatory support for cancer data reporting, is substantially propelling the demand for efficient and adaptable cancer registry systems worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators

Global Cancer Registry Software Market Size by Type & CAGR (2024-2031)

• Market Overview
• Standalone Software
• Integrated Software

Global Cancer Registry Software Market Size by Deployment Model & CAGR (2024-2031)

• Market Overview
• On-premises
• Cloud-based

Global Cancer Registry Software Market Size by Database & CAGR (2024-2031)

• Market Overview
• Commercial Databases
• Public Databases

Global Cancer Registry Software Market Size by Functionality & CAGR (2024-2031)

• Market Overview
• Cancer Reporting to Meet State & Federal Regulations
• Patient Care Management
• Product Outcome Evaluation
• Medical Research and Clinical Studies

Global Cancer Registry Software Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Government Organizations & Third-party Administrators (TPAS)
• Hospitals & Medical Practices
• Pharmaceutical, Biotechnology, & Medical Device Companies
• Private Payers
• Research Centers

Global Cancer Registry Software Market Size & CAGR (2024-2031)

• North America, (Type, Deployment Model, Database, Functionality, End-User)
  • US
  • Canada
• Europe, (Type, Deployment Model, Database, Functionality, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Deployment Model, Database, Functionality, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Deployment Model, Database, Functionality, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Deployment Model, Database, Functionality, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDITECH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Health System
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TomoTherapy Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Information Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ONCO, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conduent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ordinate Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Volpara Health Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation